Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc.（ACHV）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ACHV · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
6
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Achieve Life Sciences, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
ACHV 季度内部人买卖趋势
ACHV 内幕交易卖出 · ACHV 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · ACHV CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ACHV 高管卖出股份 · ACHV 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Sep 18, 2025 | Oki Mark K CFO | Option | 168,000 | — | Form 4 |
| Sep 18, 2025 | Oki Mark K CFO | Sale | 50,060 | $146K | Form 4 |
| Sep 18, 2025 | Stewart Richard Alistair CEO · Director | Option | 297,500 | — | Form 4 |
| Sep 18, 2025 | Stewart Richard Alistair CEO · Director | Sale | 129,501 | $378K | Form 4 |
| Sep 4, 2025 | Wan Jerry PAO | Option | 34,100 | — | Form 4 |
| Sep 4, 2025 | Wan Jerry PAO | Sale | 14,070 | $39K | Form 4 |
| Sep 4, 2025 | KING THOMAS BRAXTON Director | Option | 455,000 | — | Form 4 |
| Sep 4, 2025 | KING THOMAS BRAXTON Director | Sale | 139,858 | $387K | Form 4 |
| Sep 4, 2025 | JACOBS CINDY President & CMO | Option | 110,000 | — | Form 4 |
| Sep 4, 2025 | JACOBS CINDY President & CMO | Sale | 27,629 | $77K | Form 4 |
| Sep 4, 2025 | Xinos Jaime Chief Commercial Officer | Option | 69,000 | — | Form 4 |
| Sep 4, 2025 | Xinos Jaime Chief Commercial Officer | Sale | 20,854 | $58K | Form 4 |
| Mar 17, 2025 | Oki Mark K CFO | Purchase | 10,000 | $29K | Form 4 |
| Mar 17, 2025 | Stewart Richard Alistair Chieve Executive Officer · Director | Purchase | 10,000 | $29K | Form 4 |
| Aug 16, 2024 | Wan Jerry PAO | Award | 2,857 | $10K | Form 4 |
| Aug 16, 2024 | JACOBS CINDY President & CMO · Director | Award | 2,660 | $10K | Form 4 |
| Aug 16, 2024 | Bencich John CEO · Director | Award | 5,000 | $18K | Form 4 |
| Apr 19, 2024 | Wan Jerry PAO | Option | 5,625 | — | Form 4 |
| Apr 19, 2024 | Wan Jerry PAO | Other | 2,250 | $10K | Form 4 |
| Apr 19, 2024 | JACOBS CINDY President & CMO · Director | Option | 16,250 | — | Form 4 |
| Apr 19, 2024 | JACOBS CINDY President & CMO · Director | Other | 3,957 | $18K | Form 4 |
| Apr 19, 2024 | Stewart Richard Alistair Executive Chairman · Director | Option | 22,500 | — | Form 4 |
| Apr 19, 2024 | Stewart Richard Alistair Executive Chairman · Director | Other | 10,125 | $46K | Form 4 |
| Apr 19, 2024 | Bencich John CEO · Director | Option | 25,000 | — | Form 4 |
Stewart Richard Alistair
Chieve Executive Officer · Director
日期
Mar 17
股数
10,000
均价
$2.86
总金额
$29K
Stewart Richard Alistair
Executive Chairman · Director
日期
Apr 19
股数
22,500
均价
—
总金额
—
Stewart Richard Alistair
Executive Chairman · Director
日期
Apr 19
股数
10,125
均价
$4.51
总金额
$46K
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ACHV 内幕交易
ACHV 内幕交易
Achieve Life Sciences, Inc.（ACHV）内幕交易数据来源于公司内部人（包括Oki Mark K (CFO), Stewart Richard Alistair (CEO · Director), Wan Jerry (PAO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。ACHV内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Achieve Life Sciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ACHV 内幕交易 · 5个问题Achieve Life Sciences, Inc.（ACHV）的内部人包括高管和董事，如Oki Mark K (CFO), Stewart Richard Alistair (CEO · Director), Wan Jerry (PAO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026